State Of New Jersey Common Pension Fund D Has Cut Tenet Healthcare (THC) Stake; SANTHERA PHARMACEUTICALS HOLDINGS LTD NA (SPHDF) Sellers Increased By 140.61% Their Shorts

June 17, 2018 - By Ellis Scott

Tenet Healthcare Corporation (NYSE:THC) Logo

SANTHERA PHARMACEUTICALS HOLDINGS LTD NA (OTCMKTS:SPHDF) had an increase of 140.61% in short interest. SPHDF’s SI was 219,200 shares in June as released by FINRA. Its up 140.61% from 91,100 shares previously. The SI to SANTHERA PHARMACEUTICALS HOLDINGS LTD NA’s float is 4.65%. It closed at $18.13 lastly. It is down 0.00% since June 17, 2017 and is . It has underperformed by 12.57% the S&P500.

State Of New Jersey Common Pension Fund D decreased Tenet Healthcare Corp (THC) stake by 87.27% reported in 2018Q1 SEC filing. State Of New Jersey Common Pension Fund D sold 1.80 million shares as Tenet Healthcare Corp (THC)’s stock rose 80.76%. The State Of New Jersey Common Pension Fund D holds 262,500 shares with $6.37 million value, down from 2.06 million last quarter. Tenet Healthcare Corp now has $3.71 billion valuation. The stock decreased 0.68% or $0.25 during the last trading session, reaching $36.31. About 1.65M shares traded. Tenet Healthcare Corporation (NYSE:THC) has risen 95.96% since June 17, 2017 and is uptrending. It has outperformed by 83.39% the S&P500. Some Historical THC News: ; 26/04/2018 – Tenet Completes Purchase of USPI from WCAS; 04/05/2018 – Tenet to Participate in the Deutsche Bank Annual Health Care Conference; 26/03/2018 – TENET HEALTHCARE – GLENVIEW WITHDRAWN PROPOSAL TO AMEND CO’S BYLAWS THAT WOULD ALLOW SHAREHOLDERS TO TAKE ACTION BY WRITTEN CONSENT WITHOUT A MEETING; 18/05/2018 – Tenet to Participate in the Barclay’s High Yield Bond & Syndicated Loan Conference; 23/05/2018 – Tenet Diagnostics Examines the Role of Pharmacogenomic Testing to Lower Medication Costs and Overall Healthcare Expenditures at; 05/03/2018 – Tenet Healthcare: Eliminating Executive Committee as Standing Committee of Board; 08/05/2018 – Tenet Diagnostics Supports Monitoring Gabapentin as ‘Drug of Concern’ Amid Staggering Utilization by Opioid Users and Misuse of Medication as New Way to Get High; 05/03/2018 – TENET CUTS STK THRESHOLD NEEDED FOR HOLDERS TO CALL SPECIAL MTG; 15/05/2018 – Scopia Capital Management Buys New 2% Position in Tenet; 30/03/2018 – LACERA: RFP: Real Estate THC Audit and Tax Services and Responses to Questions

Investors sentiment decreased to 0.87 in 2018 Q1. Its down 0.01, from 0.88 in 2017Q4. It dropped, as 25 investors sold THC shares while 77 reduced holdings. 35 funds opened positions while 54 raised stakes. 109.21 million shares or 3.88% less from 113.62 million shares in 2017Q4 were reported. Swiss Savings Bank holds 0.01% of its portfolio in Tenet Healthcare Corporation (NYSE:THC) for 175,600 shares. Sg Americas Ltd Liability Co holds 41,928 shares. Parametric Port Associate Limited Co has 0.02% invested in Tenet Healthcare Corporation (NYSE:THC). Sei Investments has 0.04% invested in Tenet Healthcare Corporation (NYSE:THC). Davidson Kempner Capital Mngmt Limited Partnership accumulated 2.44% or 3.83M shares. Cibc Ww stated it has 0% of its portfolio in Tenet Healthcare Corporation (NYSE:THC). Legal And General Gp Public Ltd Com owns 273,759 shares. 54,722 were accumulated by Arizona State Retirement. Point72 Asset LP accumulated 0.02% or 244,300 shares. West Family Invests Inc has invested 0.42% in Tenet Healthcare Corporation (NYSE:THC). Northwestern Mutual Wealth Mgmt Co owns 3,057 shares. Huber Capital Management Ltd Liability Corp owns 339,500 shares. The New York-based Quantbot Techs Lp has invested 0.04% in Tenet Healthcare Corporation (NYSE:THC). Element Cap Mngmt Limited Liability Company invested in 0.01% or 16,325 shares. Aperio Grp Ltd holds 0.01% or 57,847 shares in its portfolio.

Among 23 analysts covering Tenet Healthcare Corporation (NYSE:THC), 10 have Buy rating, 4 Sell and 9 Hold. Therefore 43% are positive. Tenet Healthcare Corporation had 86 analyst reports since July 21, 2015 according to SRatingsIntel. Deutsche Bank maintained Tenet Healthcare Corporation (NYSE:THC) on Thursday, August 10 with “Buy” rating. Goldman Sachs reinitiated the shares of THC in report on Tuesday, July 21 with “Neutral” rating. The stock has “Underweight” rating by JP Morgan on Monday, March 5. Mizuho maintained Tenet Healthcare Corporation (NYSE:THC) rating on Wednesday, May 9. Mizuho has “Buy” rating and $3500 target. The firm has “Hold” rating by RBC Capital Markets given on Monday, July 17. The firm earned “Hold” rating on Tuesday, April 17 by SunTrust. The stock has “Underweight” rating by Morgan Stanley on Wednesday, February 28. The rating was maintained by Citigroup on Thursday, March 1 with “Buy”. The firm has “Buy” rating by Mizuho given on Thursday, March 22. Jefferies maintained it with “Buy” rating and $23.0 target in Tuesday, February 27 report.

Analysts await Tenet Healthcare Corporation (NYSE:THC) to report earnings on August, 6. They expect $0.23 earnings per share, up 235.29% or $0.40 from last year’s $-0.17 per share. THC’s profit will be $23.47M for 39.47 P/E if the $0.23 EPS becomes a reality. After $0.57 actual earnings per share reported by Tenet Healthcare Corporation for the previous quarter, Wall Street now forecasts -59.65% negative EPS growth.

State Of New Jersey Common Pension Fund D increased At&T Inc (NYSE:T) stake by 1.00M shares to 4.70M valued at $167.57M in 2018Q1. It also upped Park Hotels Resorts Inc stake by 55,000 shares and now owns 271,520 shares. Ultra Clean Hldgs Inc (NASDAQ:UCTT) was raised too.

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, engages in the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases in the areas of various orphan and niche indications in the European Union and internationally. The company has market cap of $117.41 million. It offers Raxone for the treatment of LeberÂ’s hereditary optic neuropathy and Duchenne muscular dystrophy. It currently has negative earnings. The firm is also developing Raxone, which is in Phase II trial for the treatment of patients with primary progressive multiple sclerosis; and omigapil that is in Phase I trial for the treatment of congenital muscular dystrophies.

Tenet Healthcare Corporation (NYSE:THC) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>